News
XenoGesis to attend DMDG
-XenoGesis will be attending the DMDG Joint Meeting, held in partnership with the Swedish Academy of Pharmaceutical Sciences. The event…
Richard Weaver to co-chair Pharma Integrates 2018
-Richard Weaver will be co-chairing this year’s Pharma Integrates conference, which takes place in London on the 12-13 November. Now…
Inhibitor for late-stage prostate cancer enters clinic
-CellCentric is beginning clinical testing of CCS1477, a novel, first-in-class drug for late-stage prostate cancer, following regulatory clearance in the…
XenoGesis supported TropIQ’s research into vector-borne disease control
-XenoGesis worked with TropIQ to support their research project into oral insecticides for vector-borne disease control, the findings of which…
XenoGesis to expand into Discovery Building
-XenoGesis is delighted to announce that it will be the next tenant to move into BioCity Nottingham’s state-of-the-art Discovery Building,…